Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07356843 · ClinicalTrials.gov registry record

Palliative Care for People With HF

A clinical trial of Congestive Heart Failure and Congestive Heart Failure(CHF), sponsored by Indiana University.

Recruiting
Registry status
20
Enrollment target
1
Study location

NCT07356843: Recruiting study of Congestive Heart Failure and Congestive Heart Failure(CHF), sponsored by Indiana University.

NCT07356843 is a study of Congestive Heart Failure and Congestive Heart Failure(CHF) that is actively recruiting participants, run by Indiana University. The registered enrollment target is 20 participants, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07356843, a study of Congestive Heart Failure and Congestive Heart Failure(CHF), is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

Imagine having heart failure, a condition where the heart struggles to pump blood, making daily life hard. People with heart failure often don't feel well and end up going to the hospital a lot. Many of these people could feel better with extra help, but there aren't many programs that offer support beyond usual heart failure treatments. That's where the ADAPT program comes in, which stands for "Advancing Symptom Alleviation with Palliative Treatment." In this program, nurses and social workers call people weekly, helping them manage their toughest symptoms, offering tools to cope with heart failure, and keeping the patients' current doctors involved. We tested this program in a research study with heart failure patients and found that it improved their quality of life and lowered depression, anxiety, and heart failure symptoms. We now want to see if the ADAPT program will work in the community, outside of a research setting, so that more people could benefit from it. Specifically, we want to know: can the ADAPT program work well in new places? Will patients and their families find it helpful? Most importantly, can it help improve the lives of people with heart failure in these new settings? To answer these questions, I'll team up with healthcare providers to 1) ask how we can adjust the ADAPT program to work well in various settings (e.g. primary care, heart failure clinic) and 2) use this information to create simple materials and trainings to help them easily provide ADAPT. This will prepare us for the next phase of this project to test out the new ADAPT program.

Primary Outcome

Qualitative themes from interviews and clinic observations and descriptive summary statistics (e.g. means, percentages) of barriers and facilitators from pCAT and PCSI surveys.

Interventions

  • OTHER ADAPT

Study Locations (1)

Indiana

  • IUHealth - Indianapolis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-10-20
Est. Completion 2028-09
Indiana University

890 total trials

What NCT07356843 shows while recruiting

NCT07356843 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (94% lower).

The record links to 3 conditions, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which ADAPT is the first listed.

NCT07356843 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT07356843 about?

NCT07356843 is a clinical study titled "Palliative Care for People With HF". Imagine having heart failure, a condition where the heart struggles to pump blood, making daily life hard. People with heart failure often don't feel well and end up going to the hospital a lot. Many of these people could feel better with extra help, but there aren't many programs that offer support...

What is the current status of trial NCT07356843?

This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-10-20. Estimated completion is 2028-09.

What conditions does trial NCT07356843 study?

This clinical trial studies the following conditions: Congestive Heart Failure, Congestive Heart Failure(CHF), Congestive Heart Failure Chronic.

What interventions are being tested in trial NCT07356843?

The interventions under investigation include: ADAPT (OTHER).

Who is sponsoring clinical trial NCT07356843?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07356843 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congestive Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07356843's enrollment target sits among peer trials

20 46th of 51 higher than 6 of 51 other Congestive Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07356843, the US trial registry maintained by the National Library of Medicine. NCT07356843 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.